Table 1.
Comparison of clinical baselines for different metastasis status subgroups.
| Characteristic | Non-Metastasis | Metastasis | All * |
|---|---|---|---|
| n | 78 | 64 | 294 |
| M, n (%) | |||
| M0 | 78 (100%) | 25 (39.1%) | 111 (37.8%) |
| M1 | 0 (0%) | 9 (14.1%) | 9 (3.1%) |
| MX | 0 (0%) | 30 (46.8%) | 174 (59.1%) |
| N, n (%) | |||
| N0 | 78 (100%) | 2 (3.1%) | 129 (43.9%) |
| N1 | 0 (0%) | 57 (89.1%) | 57 (19.4%) |
| NX | 0 (0%) | 5 (7.8%) | 108 (36.7%) |
| T, n (%) | |||
| T1 | 56 (71.8%) | 30 (46.9%) | 134 (45.6%) |
| T2 | 20 (25.6%) | 22 (34.4%) | 71 (24.2%) |
| T3 | 2 (2.6%) | 7 (10.9%) | 20 (6.8%) |
| T4 | 0 (0%) | 3 (4.7%) | 8 (2.7%) |
| Tis | 0 (0%) | 1 (1.6%) | 1 (0.3%) |
| TX | 0 (0%) | 1 (1.6%) | 60 (20.4%) |
| age, mean ± SD | 47.26 ± 12.88 | 45.36 ± 11.93 | 48.22 ± 13.91 |
* All refers to all samples with microbial information; Tis: tumor in situ.